학술논문
Multi-omic alterations of the SWI/SNF complex define a clinical subgroup in lung adenocarcinoma.
Document Type
Article
Author
Source
Subject
*ADENOCARCINOMA
*LUNGS
*OVERALL survival
*
*
Language
ISSN
1868-7075
Abstract
SWI/SNF complexes are major targets of mutations in cancer. Here, we combined multiple "-omics" methods to assess SWI/SNF composition and aberrations in LUAD. Mutations in lung SWI/SNF subunits were highly recurrent in our LUAD cohort (41.4%), and over 70% of the mutations were predicted to have functional impact. Furthermore, SWI/SNF expression in LUAD suffered an overall repression that could not be explained exclusively by genetic alterations. Finally, SWI/SNF mutations were associated with poorer overall survival in TCGA-LUAD. We propose SWI/SNF-mutant LUAD as a separate clinical subgroup with practical implications. [ABSTRACT FROM AUTHOR]